Full-Time

Vice President

Human Resources Business Partner

Posted on 4/30/2024

Revolution Medicines

Revolution Medicines

201-500 employees

Develops precision oncology therapies

Biotechnology

Senior

San Carlos, CA, USA

Required Skills
Mergers & Acquisitions (M&A)
PowerPoint/Keynote/Slides
Requirements
  • 15+ years' experience within Human Resources (or transferable experience) in expanding roles with 8+ years of people leader experience
  • Strong biotech or pharma business acumen
  • Ability to balance strategic elevation with detail orientation
  • Experience building strong trust partnerships across functional teams and at all levels of leadership
  • Accustomed to working in a matrixed and dynamic environment
  • Robust collaboration skills
  • Strong organizational, process development, and project management skills
  • Strong MS office skills (Outlook, Word, PowerPoint, and Excel)
Responsibilities
  • Lead HRBP engagement and build impactful relationships across functions and teams
  • Enhance, build, and lead the HRBP function
  • Partner in designing cross-functional human resources programs
  • Collaborate with Talent Acquisition team in full cycle recruitment
  • Consult and support different business team leaders in the development and implementation of strategies
  • Provide performance management guidance to leaders
  • Advise leaders and managers on employee matters

Revolution Medicines specializes in developing precision oncology therapies, particularly RAS(ON) inhibitors and RAS Companion inhibitors, with their lead product candidate, RMC-4630, currently in a Phase 1/2 clinical program targeting specific oncogenic mutations in various tumor types. The company's main focus is on developing these therapies to target specific oncogenic mutations in different tumor types, utilizing precision oncology technologies.

Company Stage

IPO

Total Funding

$1.3B

Headquarters

Redwood City, California

Founded

2014

Growth & Insights
Headcount

6 month growth

19%

1 year growth

50%

2 year growth

97%